64695-96-1

Basic information

• Product Name: 1-broMo-5-fluoro-2-Methyl-4-nitrobenzene
• Synonyms: 1-broMo-5-fluoro-2-Methyl-4-nitrobenzene;2-BroMo-4-fluoro-5-nitrotoluene;2-Bromo-4-fluor-5-nitrotoluene;1-broMo-5-fluoro-2-Methyl-4-nitr;Benzene, 1-bromo-5-fluoro-2-methyl-4-nitro-
• CAS NO: 64695-96-1
• Molecular Formula: C₇H₅BrFNO₂
• Molecular Weight: 234.0225032
• Mol File: 64695-96-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 287.8±35.0 °C(Predicted)
• Appearance: /
• Density: 1.696±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-broMo-5-fluoro-2-Methyl-4-nitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-broMo-5-fluoro-2-Methyl-4-nitrobenzene(64695-96-1)
• EPA Substance Registry System: 1-broMo-5-fluoro-2-Methyl-4-nitrobenzene(64695-96-1)

Safety Data

• Hazardous Substances Data: 64695-96-1(Hazardous Substances Data)

Usage

General Description

1-Bromo-5-fluoro-2-methyl-4-nitrobenzene is a chemical compound with the molecular formula C7H6BrFN2O2. It is a derivative of benzene with a bromo, fluoro, methyl, and nitro group attached to the ring. 1-broMo-5-fluoro-2-Methyl-4-nitrobenzene is a yellow solid with a molecular weight of 236.04 g/mol. It is used as an intermediate in organic synthesis and can be used to create various pharmaceuticals and agrochemicals. 1-Bromo-5-fluoro-2-methyl-4-nitrobenzene is also a halogenated aromatic compound, which means it may have uses as a building block for other chemical products. Additionally, it is important to handle this compound with care, as it may pose health and environmental risks if not properly managed.

InChI:InChI=1S/C7H5BrFNO2/c1-4-2-7(10(11)12)6(9)3-5(4)8/h2-3H,1H3

Upstream product

• 1422-53-3 2-bromo-4-fluorotoluene 

Downstream Products

• 1202858-68-1 1-bromo-5-isopropoxy-2-methyl-4-nitrobenzene 

Relevant articles and documents

ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF

An ALK kinase inhibitor compound as represented by Formula I, pharmaceutical composition containing the compound, and preparation method and use thereof in the preparation of drugs serving as an ALK inhibitor for treating cancer.

PROCESS FOR PREPARATION OF CERITINIB

The present application relates to a process for preparation of ceritinib and intermediates thereof. Specifically, the present application relates to a process for preparation of N-(4-(1-benzyl- 1,2,3,6-tetrahydropyridin-4-yl)-2-isopropoxy-5-methylphenyl)acetamide (VC) comprising treating N-(4-(bromomethyl)-2-isopropoxy-5-methylphenyl)acetamide (IIID) with 1- benzylpiperidin-4-one (IVA). The present application also relates to a process for conversion of N-(4-(1-benzyl-1,2,3,6-tetrahydropyridin-4-yl)-2-isopropoxy-5-methylphenyl)-acetamide (VC) to ceritinib or an acid-addition salt thereof.

Fluorinated tricyclic neuroleptics: 6,7 Difluoro derivative of chlorprothixene and 2-fluoro-3-hydroxy derivative of octoclothepin

-